Get started
Author

Joseba Rebollo

Irinotecan, Oxaliplatin, and 5-Fluorouracil/Leucovorin Combination Chemotherapy in Advanced Colorectal Carcinoma: A Phase II Study
2002 · Emiliano Calvo, Javier Cortés, et al. · Clinical Colorectal Cancer · 42
Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report
2011 · Belén Valenzuela, Joseba Rebollo, et al. · British Journal of Clinical Pharmacology · 23
PDF
Photodynamic therapy in the treatment of brain tumours. A feasibility study
2015 · Vicente Vanaclocha, Manuel Sureda, et al. · Photodiagnosis and Photodynamic Therapy · 20
Urokinase combination chemotherapy in small cell lung cancer. A phase II study
1992 · F. A. Calvo, O. F. Hidalgo, et al. · Cancer · 20
Fixed higher dose schedule of suramin plus hydrocortisone in patients with hormone refractory prostate carcinoma
2001 · Emiliano Calvo, Javier Cort�s, et al. · Cancer · 19
PDF
Intraoperative and External Preoperative Radiotherapy in Invasive Bladder Cancer
1993 · Felipe A. Calvo, J. Javier Aristu, et al. · American Journal of Clinical Oncology · 16
Células dendríticas I: aspectos básicos de su biología y funciones
2011 · M. Begoña Vázquez, Manuel Sureda, et al. · Inmunología · 13
Induction Platinum-Based Chemotherapy Followed by Radical Hyperfractionated Radiotherapy With Concurrent Chemotherapy in the Treatment of Locally Advanced Non-Small-Cell Carcinoma of the Lung
1999 · J. M. Lopez-Picazo, I. Azinovic, et al. · American Journal of Clinical Oncology · 13
Gene Expression Profiling of Tumors From Heavily Pretreated Patients With Metastatic Cancer for the Selection of Therapy
2014 · Joseba Rebollo, Manuel Sureda, et al. · American Journal of Clinical Oncology · 9
Neoadjuvant intra-arterial chemotherapy in inflammatory carcinoma of the breast
1992 · J. I. Bilbao, J. Rebollo, et al. · British Journal of Radiology · 9
Dosage of anti-PD-1 monoclonal antibodies: a cardinal open question
2021 · M. Sureda, E. Calvo, et al. · Clinical & Translational Oncology · 7
Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)
2011 · Elena María Martínez-Navarro, Joseba Rebollo, et al. · Clinical & Translational Oncology · 7
Use of therapeutic drug monitoring of cancer chemotherapy to modify initial per-protocol doses.
2010 · J. Rebollo, B. Valenzuela, et al. · Journal of Clinical Oncology · 5
Portal and Mesenteric Vein Thrombosis in a Patient Heterozygous for a Mutation (Arg506 → Gln) in the Factor V Gen (Factor V Leiden)
1998 · A. Piñar, R. Saenz, et al. · Journal of Clinical Gastroenterology · 5
Intra-arterial Hepatic Treatment with Carboplatin (CBDCA) and 5-Fluorouracil (5-FU) in Metastases from Colorectal Carcinoma
1993 · O. F. Hidalgo, J. Rebollo, et al. · American Journal of Clinical Oncology · 5
[Spontaneous tumor regression in a patient with metastatic gastric cancer. Communication of an additional case].
1990 · J Rebollo, I Llorente, et al. · PubMed · 5
Determining personalized treatment by gene expression profiling in metastatic breast carcinoma patients: a pilot study
2017 · M. Sureda, J. Rebollo, et al. · Clinical & Translational Oncology · 3
Radiation Therapy After High-Dose Chemotherapy With Peripheral Blood Stem Cell Support for High-Risk Breast Cancer
2002 · Marta Moreno, Ignacio Azinovic, et al. · American Journal of Clinical Oncology · 3
Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: a feasibility study
2001 · S García-Rayo, J Pérez-Calvo, et al. · Bone Marrow Transplantation · 3
[Suramin: pharmacology and antitumor effectiveness of an old parasiticide].
1994 · J Rebollo · PubMed · 3
Carboplatin (CBDCA), 5-fluorouracil (5-FU) and mitoxantrone (DHAD): An effective and well tolerated regimen for metastatic breast cancer
1992 · O.F. Hidalgo, F.G. Gonzalez, et al. · Annals of Oncology · 3
High dose chemotherapy with peripheral blood stem cell (PBSC) support in solid tumours: preliminary results.
1990 · S Martín Algarra, M Sureda, et al. · PubMed · 3
Photodynamic therapy (PDT) in the multidisciplinary treatment of brain tumors: A feasibility study.
2011 · M. S. Gonzalez, V. Vanaclocha, et al. · Journal of Clinical Oncology · 2
A phase II study of Recchia's immunomodulatory schedule (RIS) as a maintenance therapy in high-risk tumors after a response.
2013 · Manuel Sureda, Joseba Rebollo, et al. · Journal of Clinical Oncology · 1
Abstract 2213: Influence of genetic polymorphism in UGT1A1, UGT1A7 and UGT1A9 on irinotecan, SN-38 and SN-38G pharmacokinetics.
2013 · Belen Valenzuela, Mario González-Sales, et al. · Cancer Research · 1
Works count: 62
Citation count: 246
H-index: 9
I10-index: 8
Year
Topic
Type